Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Cost of Revenue: 2016-2024

Historic Cost of Revenue for Fortress Biotech (FBIO) over the last 9 years, with Dec 2024 value amounting to $20.9 million.

  • Fortress Biotech's Cost of Revenue rose 28.72% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year increase of 9.30%. This contributed to the annual value of $20.9 million for FY2024, which is 8.80% down from last year.
  • Per Fortress Biotech's latest filing, its Cost of Revenue stood at $20.9 million for FY2024, which was down 8.80% from $22.9 million recorded in FY2023.
  • Over the past 5 years, Fortress Biotech's Cost of Revenue peaked at $32.1 million during FY2021, and registered a low of $14.6 million during FY2020.
  • Over the past 3 years, Fortress Biotech's median Cost of Revenue value was $22.9 million (recorded in 2023), while the average stood at $24.8 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 119.84% in 2021, then declined by 25.61% in 2023.
  • Yearly analysis of 5 years shows Fortress Biotech's Cost of Revenue stood at $14.6 million in 2020, then surged by 119.84% to $32.1 million in 2021, then dropped by 4.08% to $30.8 million in 2022, then dropped by 25.61% to $22.9 million in 2023, then dropped by 8.80% to $20.9 million in 2024.